Allurion Technologies Q2 2023 Earnings Report $0.31 -0.01 (-1.65%) (As of 05:44 PM ET) Earnings HistoryForecast Allurion Technologies EPS ResultsActual EPS-$2.17Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AAllurion Technologies Revenue ResultsActual Revenue$12.96 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AAllurion Technologies Announcement DetailsQuarterQ2 2023Date10/20/2023TimeN/AConference Call ResourcesPress ReleaseALUR Earnings HistoryPowered by 2025’s #1 Trump Trade (Ad)All the Energy You Need to Power Your Entire Life... Could Fit Inside This Single Soda Can. Three Companies Set to See Enormous Profit Potential.Details Here. Allurion Technologies Earnings HeadlinesAllurion Technologies files $100M mixed securities shelfDecember 11, 2024 | markets.businessinsider.comAllurion Technologies files to sell common stock, warrants, no amount givenDecember 11, 2024 | markets.businessinsider.com2025’s #1 Trump TradeAll the Energy You Need to Power Your Entire Life... Could Fit Inside This Single Soda Can. Three Companies Set to See Enormous Profit Potential.December 18, 2024 | The Oxford Club (Ad)Allurion Technologies files for $100M mixed securities shelfDecember 11, 2024 | msn.comAllurion Tech announces NYSE acceptance of plan to regain listing complianceDecember 2, 2024 | markets.businessinsider.comAllurion Announces NYSE Acceptance of Plan to Regain Listing ComplianceDecember 2, 2024 | gurufocus.comSee More Allurion Technologies Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Allurion Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Allurion Technologies and other key companies, straight to your email. Email Address About Allurion TechnologiesAllurion Technologies (NYSE:ALUR) focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.View Allurion Technologies ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles History Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of Earnings Upcoming Earnings Cintas (12/19/2024) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
